Ibere Pharmaceuticals (IBER)
Ibere Pharmaceuticals operates in the Shell Companies industry of the Financial Services sector, headquartered in Philadelphia, PA, US. The stock last traded at $10.18, down 0.29% on the session, giving a market capitalisation of $175.6M. On trailing twelve-month figures it carries a trailing P/E of 29.94, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Ibere Pharmaceuticals is most often compared with the following Financial Services names: